Published in J Med Vet Mycol on January 01, 1993
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev (1995) 8.81
Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol (1997) 5.86
Molecular probes for diagnosis of fungal infections. J Clin Microbiol (1995) 3.29
Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol (1995) 2.75
Rapid identification of Candida species in blood cultures by a clinically useful PCR method. J Clin Microbiol (1997) 2.46
Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J Clin Microbiol (1995) 2.40
Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol (2002) 2.31
Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment. J Clin Microbiol (1994) 2.15
Detection of Candida albicans and other yeasts in blood by PCR. J Clin Microbiol (1994) 2.13
Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood. J Clin Microbiol (1997) 2.13
Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev (1997) 2.11
Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Clin Microbiol (1995) 1.93
Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev (1993) 1.88
PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi. J Clin Microbiol (1995) 1.73
PCR identification of four medically important Candida species by using a single primer pair. J Clin Microbiol (1994) 1.72
Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev (2002) 1.59
Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes. J Clin Microbiol (1999) 1.56
Rapid identification of Candida species by DNA fingerprinting with PCR. J Clin Microbiol (1996) 1.52
Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J Clin Microbiol (1998) 1.35
Rapid identification and fingerprinting of Candida krusei by PCR-based amplification of the species-specific repetitive polymorphic sequence CKRS-1. J Clin Microbiol (1997) 1.35
Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol (2008) 1.33
Specific detection of fusarium species in blood and tissues by a PCR technique. J Clin Microbiol (1999) 1.19
Characterization of Coccidioides immitis isolates by restriction fragment length polymorphisms. J Clin Microbiol (1994) 1.03
Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis. Eur J Clin Microbiol Infect Dis (1997) 1.01
Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis. J Clin Microbiol (2006) 0.95
Typing of Candida glabrata in clinical isolates by comparative sequence analysis of the cytochrome c oxidase subunit 2 gene distinguishes two clusters of strains associated with geographical sequence polymorphisms. J Clin Microbiol (2000) 0.93
Reverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from candida species, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples. J Clin Microbiol (2000) 0.88
Molecular characterization of Yarrowia lipolytica and Candida zeylanoides isolated from poultry. Appl Environ Microbiol (2000) 0.85
Detection of Aspergillus fumigatus PCR products by a microtitre plate based DNA hybridisation assay. J Clin Pathol (1998) 0.83
Molecular characterization of drug-resistant and drug-sensitive Aspergillus isolates causing infectious keratitis. Indian J Ophthalmol (2011) 0.80
History of medical mycology in the united states. Clin Microbiol Rev (1996) 0.78
Isolation and characterization of a species-specific DNA fragment for identification of Candida (Torulopsis) glabrata by PCR. J Clin Microbiol (2001) 0.77
Exact prediction of a natural T cell epitope. Eur J Immunol (1991) 2.90
Comparison of mycobacteria growth indicator tube with BACTEC 460 for detection and recovery of mycobacteria from clinical specimens. J Clin Microbiol (1996) 2.88
Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J Immunol (1996) 2.70
Retracted Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med (2000) 2.64
T-cell epitope mapping by flow cytometry. Nat Med (1998) 2.56
Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest (1992) 2.25
Evaluation of the Septi-Chek AFB system in the recovery of mycobacteria. Eur J Clin Microbiol Infect Dis (1992) 1.92
Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature (1992) 1.76
Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies. Bioinformatics (2004) 1.72
Sources of nonlinearity in cDNA microarray expression measurements. Genome Biol (2001) 1.70
Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Electrophoresis (1999) 1.66
A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. Proc Natl Acad Sci U S A (1993) 1.63
Cystic fibrosis deletion mutation detected by PCR-mediated site-directed mutagenesis. Clin Chem (1990) 1.56
Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma: evidence for possible superantigen involvement. Br J Dermatol (2004) 1.53
Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J Hum Virol (1999) 1.50
An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics (2000) 1.42
Induction of regulatory T-lymphocyte responses by liposomes carrying major histocompatibility complex molecules and foreign antigen. Nature (1985) 1.34
Collaboration of helper and cytotoxic T lymphocytes. Eur J Immunol (1993) 1.08
Detecting multiple cystic fibrosis mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin Chem (1991) 1.07
Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut (2005) 1.05
Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J Exp Med (1995) 1.05
Bile acid synthesis by cultured hepatocytes. Inhibition by mevinolin, but not by bile acids. J Biol Chem (1983) 1.02
Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc Natl Acad Sci U S A (1996) 0.97
Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int J Cancer (2000) 0.95
Analysis of a naturally occurring HLA class I-restricted viral epitope. Immunology (1994) 0.94
Tolerance to amino acid variations in peptides binding to the major histocompatibility complex class I protein H-2Kb. J Biol Chem (1995) 0.91
Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines. Biochim Biophys Acta (2000) 0.91
Combined laser tweezers and dielectric field cage for the analysis of receptor-ligand interactions on single cells. Electrophoresis (2001) 0.91
Identification of the testis-specific protein 10 (TSGA10) as serologically defined tumour-associated antigen in primary cutaneous T-cell lymphoma. Br J Dermatol (2005) 0.88
Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL. J Immunol (1996) 0.87
Lack of DNA evidence for jaagsiekte sheep retrovirus in human bronchioloalveolar carcinoma. Hum Pathol (2002) 0.87
Genotype-phenotype correlation and frequency of the 3199del6 cystic fibrosis mutation among I148T carriers: results from a collaborative study. Genet Med (2004) 0.86
Determination of carrier status in Duchenne and Becker muscular dystrophies by quantitative polymerase chain reaction and allele-specific oligonucleotides. Clin Chem (1990) 0.86
Determination of T cell epitopes with random peptide libraries. J Immunol Methods (1996) 0.85
Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries. J Biol Chem (1998) 0.85
Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries. Eur J Immunol (2001) 0.85
Screening Young syndrome patients for CFTR mutations. Am J Respir Crit Care Med (1995) 0.83
A model for molecular screening of newborns: simultaneous detection of Duchenne/Becker muscular dystrophies and cystic fibrosis. Clin Chem (1990) 0.83
Antigen presentation by liposomes: inhibition with antibodies. Eur J Immunol (1986) 0.83
Molecular probe protocol for determining carrier status in Duchenne and Becker muscular dystrophies. Clin Chem (1990) 0.82
Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. J Immunol Methods (1994) 0.82
A CFTR mutation (D1152H) in a family with mild lung disease and normal sweat chlorides. Clin Genet (2005) 0.80
Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein. Urology (2001) 0.80
A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma. Ann Oncol (2000) 0.80
Heteroduplex generator in analysis of Rh blood group alleles. Clin Chem (1996) 0.80
CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression. J Immunol (1994) 0.80
Rapid DNA haplotyping using a multiplex heteroduplex approach: application to Duchenne muscular dystrophy carrier testing. Hum Mutat (1995) 0.80
Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice. Eur J Immunol (1993) 0.80
Residual minor histocompatibility genes contaminate the B10.AM congenic line: no evidence of C-region-controlled histoincompatibility. Scand J Immunol (1983) 0.80
Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR. J Virol Methods (2005) 0.79
Distribution of alloreactivity among antigen-specific, class II-restricted T-cell clones and hybridomas. Immunogenetics (1985) 0.79
Electrophoresis-related protein modification: alkylation of carboxy residues revealed by mass spectrometry. Electrophoresis (1998) 0.79
T cell receptor specificity and mimotopes. Curr Opin Immunol (1999) 0.79
Confirmation of the presence of Mycobacterium tuberculosis and other mycobacteria in mycobacterial growth indicator tubes (MGIT) by multiplex strand displacement amplification. J Clin Microbiol (1997) 0.79
Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes. Cancer Immunol Immunother (1994) 0.78
Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection. Mod Pathol (1998) 0.77
Cancer stem cells in melanoma. Ecancermedicalscience (2008) 0.77
Peptide binding to MHC class I molecules analyzed by confocal microscopy. Eur J Cell Biol (1995) 0.77
Identification of epitopes for CTCL-specific cytotoxic T lymphocytes. Adv Exp Med Biol (1998) 0.77
Peptide length preferences for rat and mouse MHC class I molecules using random peptide libraries. Eur J Immunol (1998) 0.77
Cutaneous malignant lymphomas. Immunol Today (1998) 0.76
Hybrid cell vaccination in cancer immunotherapy. Recruitment and activation of T cell help for induction of anti tumour cytotoxic T cells. Adv Exp Med Biol (1998) 0.76
Mild cystic fibrosis linked to chromosome 7q22 markers with an uncommon haplotype. Ann Intern Med (1989) 0.76
Neonatal screening for biotinidase deficiency. Ann Clin Lab Sci (1992) 0.76
Molecular characterization of signalling pathways in cancer stem cells. Ecancermedicalscience (2008) 0.75
Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice. Immunology (1995) 0.75
Gene therapy of cancer. Immunol Today (1998) 0.75
WHAT CAN THE MODERN CHEMIST LEARN FROM THE OLD ALCHEMY? Science (1927) 0.75
T cell response to myoglobin: a comparison of T cell clones in high-responder and low-responder mice. Eur J Immunol (1988) 0.75
A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma. Adv Exp Med Biol (1998) 0.75
Do halo nuclei follow Rutherford elastic scattering at energies below the barrier? The case of 11Li. Phys Rev Lett (2012) 0.75
Incorrect attribution of peptide source. Cell (1993) 0.75
Hybrid cell vaccination in patients with metastatic melanoma. Methods Mol Med (2000) 0.75
Breast cancer trials--a new initiative. Br Med J (1980) 0.75
Measurement of the 18Ne(α,p0) 21Na reaction cross section in the burning energy region for x-ray bursts. Phys Rev Lett (2012) 0.75
The future of vaccination as a treatment strategy in dermatological diseases. Clin Exp Dermatol (2002) 0.75
Beta-delayed deuteron emission from (11)Li: decay of the halo. Phys Rev Lett (2008) 0.75
Amino acid preferences in the octapeptide subunit of the major histocompatibility complex class I heterotrimer H-2Ld. Eur J Biochem (1996) 0.75
Antigen presentation by liposomes. Haematol Blood Transfus (1985) 0.75
Mimetics of a T cell epitope based on poly-N-acylated amine backbone structures induce T cells in vitro and in vivo. J Biol Chem (2001) 0.75
N-Hydroxy-amide analogues of MHC-class I peptide ligands with nanomolar binding affinities. J Pept Sci (1998) 0.75
Fine specificity analysis of lactate dehydrogenase B-specific proliferating T cell clones: implications for the mechanism of alloreactivity. Eur J Immunol (1985) 0.75
Automation and the single-gene disorder: cystic fibrosis as a model. Clin Chem (1992) 0.75
The hybrid cell vaccination approach to cancer immunotherapy. Ernst Schering Res Found Workshop (2000) 0.75
Altered allogeneic response in neonatally anti-MHC class I-treated mice. Scand J Immunol (1996) 0.75
Mismatch cleavage detects base deletion in cystic fibrosis gene. Biotechniques (1998) 0.75
Composition of a suppressor factor that inhibits the immune response to lactate dehydrogenase B. Scand J Immunol (1984) 0.75
Retrograde ejaculation. Lancet (1969) 0.75
Cutting edge: N-hydroxy peptides: a new class of TCR antagonists. J Immunol (1999) 0.75
H-2 haplotypes carrying identical D but different L alleles. Tissue Antigens (1983) 0.75
Improved enzymatic hydrolysis of conjugated bile acids. Lipids (1987) 0.75
Measurement of the two-halo neutron transfer reaction (1)H((11)Li, (9)Li)(3)H at 3A MeV. Phys Rev Lett (2008) 0.75
New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules. J Biol Chem (1998) 0.75